Back to Directory
Insulin Detemir
Performance & EnduranceLong-acting basal insulin with albumin binding for extended duration, marketed as Levemir.
Key Benefits
- ✓Long-acting basal coverage
- ✓Less weight gain than other insulins
- ✓Predictable action
- ✓Once or twice daily
- ✓Reduced nocturnal hypoglycemia
Dosing Information
Dosage Range
Variable
Frequency
Once or twice daily
Typical Duration
Lifelong
Detailed Protocol
Administered subcutaneously once or twice daily depending on needs. Basal insulin independent of meals. Dose individualized.
About Insulin Detemir
Insulin detemir (Levemir) is a long-acting insulin analog with a fatty acid side chain that promotes albumin binding, extending duration of action. Provides relatively flat basal coverage for up to 24 hours.
Research Notes
FDA-approved in 2005. Unique fatty acid modification. Some evidence of less weight gain vs other basal insulins. May require twice-daily dosing in some patients.
Potential Side Effects
- •Hypoglycemia
- •Less weight gain vs other basals
- •Injection site reactions
- •Headache
Always consult with a healthcare professional before starting any peptide therapy.